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Comparison of structural repair following characterized 
chondrocyte implantation or microfracture for the treatment of 
symptomatic cartilage defects of the knee
D.B. Saris1, J. Vanlauwe2, J. Victor3, J. Bellemans4, F. Luyten5;
1Orthopaedics, University Medical Center, Utrecht, Utrecht, 
Netherlands, 2Orthopaedic Surgery, University Hospital Leuven, 
Leuven, Belgium, 3Orthopaedic Surgery, Medical Centre St Lukas, 
Gent, Belgium, 4Orthopedics, University Hospital Leuven, Leuven, 
Belgium, 5Rheumatology, University Hospital Leuven, Leuven, 
Belgium
Purpose: Characterized chondrocyte implantation (CCI) uses an 
autologous cell therapy product (ChondroCelect®) that has been 
optimized for the production of stable cartilage in vivo. However, 
NJDSPGSBDUVSFSFNBJOTUIFNPTUGSFRVFOUMZVTFE¾STUMJOFUSFBUNFOU
GPSDBSUJMBHF MFTJPOT JO UIFLOFF5IJTTUVEZDPNQBSFEUIFFG¾DBDZ
and safety of CCI to microfracture in the repair of symptomatic 
cartilage defects of the femoral condyle. 
Methods and Materials: CCI (n=51) was compared to microfracture 
(n=61) in patients with grade III-IV symptomatic cartilage defects 
of the femoral condyles in a prospective, multicenter, randomized, 
controlled trial. Structural repair was assessed at 1 year by 
histopathologists blinded to the treatment using (i) computerized 
histomorphometry and (ii) an overall histology assessment. Clinical 
outcome was measured using the Knee Injury and Osteoarthritis 
Outcome Score (KOOS). Safety was recorded throughout the study. 
Results: CCI resulted in better structural repair than microfracture at 
1 year post-treatment, as assessed by histomorphometry (p=0.003) 
and overall histology (p=0.012). Structural repair parameters relating 
to chondrocyte phenotype and tissue structure were also superior 
with CCI. Noninferiority of CCI was demonstrated for clinical outcome 
at 12 18 months, and both treatments were generally well tolerated. 
Conclusions: At 1 year post-treatment, CCI resulted in superior tissue 
repair compared to microfracture. Short-term clinical outcome after 
12-18 months was similar for both treatments, as was the safety 
QSP¾MF5IFTVQFSJPSTUSVDUVSBMSFQBJSBDIJFWFEXJUI$$*NBZMFBEUP
JNQSPWFEMPOHUFSNDMJOJDBMCFOF¾UT
29.5
The quality of the cartilage lesion debridement using different 
open and arthroscopic techniques
M. Drobniþ1, K. Straåar1, D. Radosavljeviþ2, A. Coer3, M. Brittberg4,
V. Pavlovþiþ2;
1Department Of Orthopaedic Surgery, University Medical Centre 
Ljubljana, Ljubljana, Slovenia, 2Department Of Orthopaedic 
Surgery, University Medical Centre, Ljubljana, Slovenia, 3Institute Of 
Histology And Embryology, Medical Faculty, University of Ljubljana, 
Ljubljana, Slovenia, 4Orthopaedic Department, Cartilage Research 
Unit, G, Kungsbacka, Sweden
Purpose: An ex-vivo study was comparing the quality of cartilage 
MFTJPO EFCSJEFNFOU UIF ¾STU BOE DSVDJBM TUBHF PG FWFSZ DBSUJMBHF
SFQBJSNFUIPECZ¾WFEJGGFSFOUPQFSBUJWFUFDIOJRVFT
Methods and Materials: Oval shapes (1.5 x 1.0 cm) were marked 
on the surfaces of fresh equine and human cadaveric femoral 
osteochondral blocks. An arthroscopic debridement of each marked 
surface by different instrumentations (SH-shaver, CU-curette, 
SHCU-shaver and curette, BP-bipolar probes) was performed in a 
TPMVUJPO¾MMFEQMBTUJDCPY0OF TFUPG CMPDLTXBTEFCSJEFECZ UIF
open technique with a scalpel and a curette (OPEN). The histological 
analysis of the transversal cuts through the lesion was focused on 
the subchondral bone, lesion walls, and cartilage rim. 
Results: The most vertical walls with least adjacent cartilage 
damage were provided by OPEN. CU and SHCU showed inferior, 
although still acceptable debridement. SH (crater-like shape) and BP 
(undermining of the cartilage rim) debridements were undesirable. 
The subchondral bone was penetrated in all equine samples, except 
with BP. The predominant debridement depth in human samples 
XBTBUUIFDBMDJ¾FEDBSUJMBHFBMUIPVHITPNFNJOPSQFOFUSBUJPOTPG
the subchondral endplate were always present (SHCU>CU>OPEN). 
Conclusions: Not all the routine arthroscopic instrumentations 
are advisable to be used in the cartilage repair surgery. The 
author’s preference after the study is the ring-curette either as 
open or arthroscopic technique. The extensive penetration of the 
subchondral bone in equine samples advocates that immature 
animals are not a good model to study the human cartilage repair. 
The clinical consequences of minor endplate penetrations in human 
samples are unclear.
29.6
Treatment of full thickness cartilage defects of the knee with the 
5SV¾UUFDIOJRVFBOE¾STUSFTVMUT
F.V. Sciarretta1, P. Versari2, A. Basile3, E. Di Cave4;
1Orthopaedy, Jewish Hospital, Rome, Italy, 2Orthopaedics, Jewish 
Hospital, Rome, Italy, 3Orthopaedy, Jewish Hospital, Rome, Italy, 
4Cartilage Restoration Unit- Foot And Ankle Dept., Jewish Hospital, 
Rome, Italy
Purpose: 1SFTFOU TVSHJDBM UFDIOJRVF BOE FBSMZ SFTVMUT PG 5SV¾UTM
bone graft substitute in treatment of full thickness chondral and 
osteochondral defects of the knee. 
Methods and Materials: 15 patients were included in the study (12 
women, 3 men). Every patient has underwent arthroscopic knee 
assessment to evaluate size, location and degree of defects. After 
staging of defects, patients with Outerbridge grade III and IV lesions 
XFSF RVBMJ¾FE GPS JNQMBOUBUJPO PG 5SV¾UTM cylindrical resorbable 
scaffold. Majority of synthetic bone substitutes implanted were 11 
mm in diameter. 
Results: All surgical procedures have been completed uneventfully. 
Patient have been controlled clinically and by serial knee MRI’s and 
TIPXFE TUBUJTUJDBMMZ TJHOJ¾DBOU JNQSPWFNFOUPG *,%$BOE80."$
scores associated to healing of defect and integration of bone plugs 
in absence of adverse reactions. 
Conclusions: Articular cartilage is characterized by limited repair 
capacity following injury. Today several methods are available for 
surgical treatment of hyaline cartilage defects. Among our institution, 
among other treatments (microfractures, ACI, SalucartilageTM and 
HemicapTM), we recently have decided to verify the capability of 
synthetic bone graft substitutes in closing defects and allowing 
ingrowth of new healing tissue. Preliminary results enable us to 
conclude that porous, resorbable scaffolds can be used in treatment 
of cartilage defects offering a secure support to secondary bone 
ingrowth with the advantage of being applied in one single step 
procedure. 
29.7
Autologous Matrix Induced Chondrogenesis (AMIC®) for focal 
chondral defects of the knee – 1-3 year results
S. Anders, J. Schaumburger, O. Wiech, J. Grifka;
Dept. Of Orthopaedics, University of Regensburg, Bad Abbach, 
Germany
Purpose: Microfracturing utilizes mesenchymal stem cells (MSC) 
for an autogenous reparation process. Autologous Matrix Induced 
Chondrogenesis (AMIC®) combines microfracturing with application 
of a porcine collagen type-I/III bilayer matrix to host the MSC and to 
stabilize the blood clot. 
Methods and Materials: 36 focal chondral/osteochondral defects 
(ICRS III-IV°) in 33 patients (Ø age of 36.2 (18-52) years) were treated 
by standardized microfracturing and application of a collagen matrix 
(Geistlich Biomaterials, Wolhusen, Switzerland). The results were 
evaluated prospectively by functional outcome scores, subjective 
clinical ratings and MRI with an average follow-up of 21 months 
(range 12-39 months). The mean defect size was 3.86 cm² (1.0 - 6.8 
cm²). 21 patients (63.6%) had undergone at least one prior surgery. 
Results: All patients rated their ICRS functional status as abnormal 
(ICRS III° (63.4%)) or severely abnormal (ICRS IV° (36.3%)). 
4UBUJTUJDBMMZTJHOJ¾DBOUJNQSPWFNFOUTXFSFTFFOGPSUIF$JODJOOBUJ
Score (51.1 to 85.1) as well for the Lysholm-Score (60.4 to 87.7, 
each p<
 1BJO EFDSFBTFE TJHOJ¾DBOUMZ GSPN  UP  XIJMF
subjective knee function improved from a mean of 4.6 to 7.5 on a 
visual 10-point scale. 4 biopsies (4-21 months) revealed reasonable 
SFTVMUTXJUISFHBSETUPTVSGBDFGPSNBUJPO¾MMJOHBOEJOUFHSBUJPO5IF
.3*GPMMPXVQTTIPXFEBOBEFRVBUF¾MMJOHPGUIFEFGFDUPGUIF
QBUJFOUTXFSFTBUJT¾FEXJUIUIFGVODUJPOBMSFTVMUT	*$34***

Conclusions: (AMIC®) is a minimal invasive, effective treatment 
option for focal cartilage defects of the knee of medium or large 
size. Without using cultured chondrocytes it can be performed cost-
effectively as a one-step procedure. 
